Answer
Apr 30, 2025 - 12:08 PM
Bromfenac was removed from the U.S. market in 1998 due to concerns about severe liver toxicity. The nonsteroidal anti-inflammatory drug (NSAID) was linked to cases of fatal liver failure, prompting its manufacturer to voluntarily withdraw it from sale.
